What if we could cut skin cancer death rates in half?
Skin cancer kills approximately 2,500 people every year in the UK (see Box 1). Moreover, more men than women die of malignant melanoma; men aged 30–34 have a 1.5 fold higher risk of dying compared to similarly aged women, and this rate increases to 1.7 fold for those aged between 55 to 64 years. There is a considerable economic burden on the NHS for treating malignant melanoma; costs were estimated to be over £105 million in 2008 – 2009 and are projected to exceed £180 million by 2020.
Dermatology in practice 2017; 23(1): 10–12
To continue reading this article, please sign in or register.